Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 1921 AL 1935

Glycometabolic Reprogramming of Microglia in Neurodegenerative Diseases: Insights from Neuroinflammation

Huang Q, Wang Y, Chen S, Liang F.

Aging Dis. 2024 May 7;15(3):1155-1175. doi: 10.14336/AD.2023.0807.

The gut microbiome: an important role in neurodegenerative diseases and their therapeutic advances

Li S, Zhao L, Xiao J, Guo Y, Fu R, Zhang Y, Xu S.

Mol Cell Biochem. 2024 Sep;479(9):2217-2243. doi: 10.1007/s11010-023-04853-6. Epub 2023 Oct 3.

Electroacupuncture stimulation to modulate neural oscillations in promoting neurological rehabilitation

Wu R, Ma H, Hu J, Wang D, Wang F, Yu X, Li Y, Fu W, Lai M, Hu Z, Feng W, Shan C, Wang C.

Brain Res. 2024 Jan 1;1822:148642. doi: 10.1016/j.brainres.2023.148642. Epub 2023 Oct 24.

Pyrrole: A Decisive Scaffold for the Development of Therapeutic Agents and Structure-Activity Relationship

Ganesh BH, Raj AG, Aruchamy B, Nanjan P, Drago C, Ramani P.

ChemMedChem. 2024 Jan 2;19(1):e202300447. doi: 10.1002/cmdc.202300447. Epub 2023 Nov 22.

Phospholipidomics in Clinical Trials for Brain Disorders: Advancing our Understanding and Therapeutic Potentials

Hachem M, Ahmmed MK, Nacir-Delord H.

Mol Neurobiol. 2024 Jun;61(6):3272-3295. doi: 10.1007/s12035-023-03793-y. Epub 2023 Nov 20.

The origins of human pluripotent stem cells: the road from a cancer to regenerative medicine

Andrews PW.

In Vitro Cell Dev Biol Anim. 2024 May;60(5):514-520. doi: 10.1007/s11626-024-00865-8. Epub 2024 Feb 23.

Fractal Dimension Analysis in Neurological Disorders: An Overview

Díaz Beltrán L, Madan CR, Finke C, Krohn S, Di Ieva A, Esteban FJ.

Adv Neurobiol. 2024;36:313-328. doi: 10.1007/978-3-031-47606-8_16.

[Advances in the application of fecal microbiota transplantation for the treatment of nervous system diseases]

Ma X, Zhang L, Gao J, Chen F.

Sheng Wu Gong Cheng Xue Bao. 2024 May 25;40(5):1293-1308. doi: 10.13345/j.cjb.230448.

Brain Targeting Nanomedicines: Pitfalls and Promise

Kakinen A, Jiang Y, Davis TP, Teesalu T, Saarma M.

Int J Nanomedicine. 2024 May 27;19:4857-4875. doi: 10.2147/IJN.S454553. eCollection 2024.

Harnessing Therapeutic Potentials of Biochanin A in Neurological Disorders: Pharmacokinetic and Pharmacodynamic Overview

Kumar A, Angelopoulou E, Pyrgelis ES, Piperi C, Mishra A.

Chem Biodivers. 2024 Aug;21(8):e202400709. doi: 10.1002/cbdv.202400709. Epub 2024 Jul 16.

Neuroprotective effects of Gypenosides: A review on preclinical studies in neuropsychiatric disorders

Liang G, Lee YZ, Kow ASF, Lee QL, Cheng Lim LW, Yusof R, Tham CL, Ho YC, Lee MT.

Eur J Pharmacol. 2024 Sep 5;978:176766. doi: 10.1016/j.ejphar.2024.176766. Epub 2024 Jun 20.

Neuronal Cell Differentiation of iPSCs for the Clinical Treatment of Neurological Diseases

Lee DH, Lee EC, Lee JY, Lee MR, Shim JW, Oh JS.

Biomedicines. 2024 Jun 18;12(6):1350. doi: 10.3390/biomedicines12061350.

Role of mitochondria-endoplasmic reticulum contacts in neurodegenerative, neurodevelopmental and neuropsychiatric conditions

Serangeli I, Diamanti T, De Jaco A, Miranda E.

Eur J Neurosci. 2024 Sep;60(5):5040-5068. doi: 10.1111/ejn.16485. Epub 2024 Aug 5.

Klotho: molecular mechanisms and emerging therapeutics in central nervous system diseases

Hosseini L, Babaie S, Shahabi P, Fekri K, Shafiee-Kandjani AR, Mafikandi V, Maghsoumi-Norouzabad L, Abolhasanpour N.

Mol Biol Rep. 2024 Aug 17;51(1):913. doi: 10.1007/s11033-024-09862-2.

DJ-1: Potential target for treatment of myocardial ischemia-reperfusion injury

Ji YW, Wen XY, Tang HP, Jin ZS, Su WT, Zhou L, Xia ZY, Xia ZY, Lei SQ.

Biomed Pharmacother. 2024 Oct;179:117383. doi: 10.1016/j.biopha.2024.117383. Epub 2024 Sep 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias